Work

Systemic Interleukin-2 and Adoptive Transfer of Lymphokine-Activated Killer Cells Improves Antibody-Dependent Cellular Cytotoxicity in Patients with Relapsed B-Cell Lymphoma Treated with Rituximab

Year: 2007

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-06-1860

Authors: Jesús G. Berdeja, Allan Hess, David M. Lucas, Paul O'Donnell, Richard F. Ambinder, Louis F. Diehl, Denise Carter-Brookins, Susan Newton, Ian W. Flinn

Institutions: Loma Linda University Medical Center, Loma Linda University Health Care, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, The Ohio State University, Fred Hutch Cancer Center, Sarah Cannon

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2163095456

FWCI: 4.24

Cites: 40

Cited by: 53

Related to: 10